Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide
Open Access
- 10 April 2002
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 16 (8), 860-862
- https://doi.org/10.1096/fj.01-0841fje
Abstract
Genetic, neuropathological, and biochemical studies have provided strong evidence for a central role of amyloid in the pathogenesis of Alzheimer's disease (AD). We have proposed previously that pepti...Keywords
This publication has 66 references indexed in Scilit:
- Inhibition of Alzheimer's disease β‐amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapyThe FASEB Journal, 2001
- Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal DepletionJournal of Biological Chemistry, 1999
- ALZHEIMER'S DISEASE: Genetic Studies and Transgenic ModelsAnnual Review of Genetics, 1998
- Conformational diseaseThe Lancet, 1997
- Passage of peptides across the blood-brain barrier: Pathophysiological perspectivesLife Sciences, 1996
- Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by RifampicinPublished by Elsevier ,1996
- Selective Inhibition of Aβ Fibril FormationJournal of Biological Chemistry, 1996
- Murine tumor necrosis factor alpha is transported from blood to brain in the mouseJournal of Neuroimmunology, 1993
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992
- Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma ProteinsJournal of Neurochemistry, 1990